Last updated: October 18, 2021
Sponsor: National Cancer Institute, Egypt
Overall Status: Active - Recruiting
Phase
N/A
Condition
Chronic Pain
Pain
Treatment
N/AClinical Study ID
NCT05083702
AP2103-30101R
Ages > 20 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age > 20 years.
- Patients with advanced stage cancer bladder.
- Patient with severe pain (VAS) 7 or more .
- Patients don't receive any strong opioids for pain at least 2 weeks
Exclusion
Exclusion Criteria:
- Patient refusal.
- Local infection at the puncture site.
- Coagulopathy.
- Cognitive disorders.
- Unstable cardiovascular disease.
- History of psychiatric disorders.
- History of drug abuse.
- Patients allergic to medication used.
- Patients with any contraindications to drugs and dye used.
Study Design
Total Participants: 60
Study Start date:
December 01, 2020
Estimated Completion Date:
October 30, 2021
Study Description
Connect with a study center
National cancer institute
Cairo,
EgyptActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.